Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study
about
Psychological interventions for treatment of inflammatory bowel diseasePatient initiated clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic review of patient reported outcomes and patient and clinician satisfactionThe clinical effectiveness of patient initiated clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic reviewOpen access follow up for inflammatory bowel disease. Would have been better to use t test than Mann-Whitney U test.Clarifications: open access follow up for inflammatory bowel diseasePatients' experiences of an open access follow up arrangement in managing inflammatory bowel disease.Distance management of inflammatory bowel disease: systematic review and meta-analysisEffect of patient-initiated versus fixed-interval telePRO-based outpatient follow-up: study protocol for a pragmatic randomised controlled study.Can electronic routine data act as a surrogate for patient-assessed outcome measures?Inflammatory bowel disease: an expanding global health problemPatient initiated outpatient follow up in rheumatoid arthritis: six year randomised controlled trial.Mann-Whitney test is not just a test of medians: differences in spread can be importantShort Form 36 (SF-36) Health Survey Questionnaire: normative data for Wales.Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-control questionnaireCost of illness of inflammatory bowel disease in the UK: a single centre retrospective study.'Real world' pragmatic clinical trials: what are they and what do they tell us?Inflammatory bowel diseases and the general practitioner's role in a region of Central Italy.Randomized controlled trials in colorectal disease; a review of recent trials.Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidenceReview article: psychosocial factors in the quality of life of patients with inflammatory bowel disease.The impact of nurse-led annual telephone follow-up of patients with inflammatory bowel disease.Contribution of specialist nurses in managing patients with IBD.The role of primary care physicians in early diagnosis and treatment of chronic gastrointestinal diseases.Cost effectiveness of treatments for inflammatory bowel disease.Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD: MyIBDcoach.Confidence intervals should be used in reporting trials.Advances in managing chronic disease. Research, performance measurement, and quality improvement are keyA United Kingdom inflammatory bowel disease database: making the effort worthwhile.Ulcerative colitis in northern Portugal and Galicia in Spain.Long-term aminosalicylate therapy is under-used in patients with ulcerative colitis: a cross-sectional survey.Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital.Exploring the role of the inflammatory bowel disease nurse specialist.Reducing the follow-up rates over three consecutive specialist registrar trainees placements.
P2860
Q24234176-2EAD20CD-8490-4F8A-8323-167306EE718EQ26824146-D0EB4EE2-7E42-426D-A264-7B9CDC2BA67AQ26995838-A578AD02-3558-45DD-BE43-DAD642964D74Q30482105-D8541A7D-748E-4E9B-B2CE-587521D4E648Q30482352-7AE1DC51-C392-48AB-B30D-A6D097A1BF27Q30482746-38EEF579-DA94-4FB5-B146-652F3618836EQ30486789-5FAA2AFF-84C9-4814-A1CE-1FF9F0CD4422Q30490784-5DD64FC3-8B9A-40DF-9857-37E1C2CF429AQ30983729-1E52E4A1-626B-4F68-A0AC-7643C762C017Q33608406-76973F59-7AB5-4114-AA76-3AC892B810B9Q33741893-740A3421-4BD4-43B3-AE26-68B146FD38B5Q33806761-D7C35B9E-AE28-4931-B6F9-BD46D3EF4508Q33816530-2713B805-8053-432D-9E2C-80821388E2A1Q33834727-7A499200-AD08-4044-BF28-DFC42F88626BQ33981316-B2166E3F-C258-48BA-9D7E-DC06DEABE1CAQ34631331-B293838C-BD54-4170-8FDF-0CD5DCA760A4Q35026337-5376910F-4758-48E4-BCFC-9183CB965C2EQ35147238-5BAA9920-478E-46DF-9A0B-07D2954B2DC7Q35768888-ED124114-31D6-447A-8638-A3355877122FQ36059004-888D0C58-45A7-4A20-898C-D4EFAE6D876DQ36281901-B29FE156-43B4-40EF-AACD-DC5B9CD75837Q36761092-318B0406-B92A-40B5-9FB7-B2205A2FD564Q37644595-2C423ED3-543F-4D9E-9621-70A403DE5947Q37832729-3DC03BED-7762-480B-8AD0-28A8C12825D0Q38749700-E2DD1140-7900-4649-8E7F-42B2BCC2E4DEQ42707042-A7258EAC-11E1-473F-BB65-F233753A938EQ42766291-16F74A09-917C-4692-8979-967E0A08ACA0Q42788666-09FA5A53-1FEB-4706-AE1C-B2B13A93CFEBQ43238853-2D7B5253-9000-4C8A-B7CC-D9ACB4CB355DQ44186826-8B6C6488-AFB6-47DD-AC88-C37947D80718Q44690723-A211B52C-3066-45FA-BEA3-F75C1587AE91Q46309057-63F5ED2D-6099-48D2-A598-A40977B74259Q53566405-1330AEE7-9AE4-4C6D-AF59-E77ADE1F580F
P2860
Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Open access follow up for infl ...... l and cost effectiveness study
@ast
Open access follow up for infl ...... l and cost effectiveness study
@en
type
label
Open access follow up for infl ...... l and cost effectiveness study
@ast
Open access follow up for infl ...... l and cost effectiveness study
@en
prefLabel
Open access follow up for infl ...... l and cost effectiveness study
@ast
Open access follow up for infl ...... l and cost effectiveness study
@en
P2093
P2860
P356
P1433
P1476
Open access follow up for infl ...... l and cost effectiveness study
@en
P2093
P2860
P304
P356
10.1136/BMJ.320.7234.544
P407
P577
2000-02-01T00:00:00Z